日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005

化疗联合放疗±阿特珠单抗治疗局限期小细胞肺癌:NRG Oncology/Alliance LU005 研究结果

Higgins, Kristin A; Hu, Chen; Ross, Helen J; Jabbour, Salma K; Kozono, David E; Owonikoko, Taofeek K; Ritter, Timothy A; Williams, Terence M; Welsh, James; Simko, Jeffry P; Movsas, B; Xiao, Canhua; Kaira, Kyoichi; Gupta, Amit K; Mohindra, Pranshu; Dib, Elie G; Brownstein, Jeremy; Chun, Stephen; Kuzma, Charles S; Kotecha, Rupesh; Onitilo, Adedayo A; Chen, Yuhchyau; Stinchcombe, Thomas E; Wang, Xiaofei; Paulus, Rebecca; Bradley, Jeffrey D

PROSPECT-LUNG: A National Clinical Trials Network Trial Advancing Pragmatic Innovation in Cancer Clinical Trials

PROSPECT-LUNG:一项推进癌症临床试验实用创新的国家临床试验网络试验

Booth, Allison; Hillman, Shauna; Laumann, Kristina; Zhao, Ying-Qi; LeBlanc, Michael; Chansky, Kari; Giri, Sharmila; Dill, Jennifer; Johnson, Judy; Kelley, Kathryn; Martin, Linda; Osarogiagbon, Raymond U; Morris, Michael J; Chiang, Anne C; Kozono, David E; Blanke, Charles D; Galanis, Evanthia; Gray, Jhanelle E; Stinchcombe, Thomas E; Aljumaily, Raid; Morgensztern, Daniel; Mandrekar, Sumithra J

CALGB 140503 and the shift to sublobar resection for small, peripheral, node-negative NSCLC: historical context, secondary analyses, and next steps

CALGB 140503 和小型、周围型、淋巴结阴性非小细胞肺癌的亚肺叶切除术转变:历史背景、二次分析和后续步骤

Chow, Oliver S; Jones, David R; Stinchcombe, Thomas E; Altorki, Nasser K

Alirocumab plus cemiplimab in advanced immuno-refractory metastatic non-small cell lung cancer: an ongoing multi-center phase II study

Alirocumab联合cemiplimab治疗晚期免疫难治性转移性非小细胞肺癌:一项正在进行的多中心II期研究

Oduah, Eziafa I; Zhang, Tian; Jung, Sin-Ho; Stinchcombe, Thomas E; Ready, Neal; Crawford, Jeffrey; Clarke, Jeffrey M; Gray, Jhanelle E; Antonia, Scott J

Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial

Tucatinib 和 trastuzumab 治疗 HER2 突变转移性乳腺癌:一项 II 期篮式试验

Okines, Alicia F C; Curigliano, Giuseppe; Mizuno, Nobumasa; Oh, Do-Youn; Rorive, Andree; Soliman, Hatem; Takahashi, Shunji; Bekaii-Saab, Tanios; Burkard, Mark E; Chung, Ki Y; Debruyne, Philip R; Fox, Jenny R; Gambardella, Valentina; Gil-Martin, Marta; Hamilton, Erika P; Monk, Bradley J; Nakamura, Yoshiaki; Nguyen, Danny; O'Malley, David M; Olawaiye, Alexander B; Pothuri, Bhavana; Reck, Martin; Sudo, Kazuki; Sunakawa, Yu; Van Marcke, Cedric; Yu, Evan Y; Ramos, Jorge; Tan, Sherry; Bieda, Mark; Stinchcombe, Thomas E; Pohlmann, Paula R

Early-Phase Trials in Journal of Clinical Oncology

《临床肿瘤学杂志》早期试验

Stinchcombe, Thomas E; Fleming, Gini F; Craddock, Charles; Ko, Andrew H; O'Reilly, Eileen M; Maki, Robert G

Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial.

针对补体因子 H 的抗体 GT103 在难治性非小细胞肺癌中的应用:一项 1b 期剂量递增试验

Clarke Jeffrey M, Simon George R, Mamdani Hirva, Gu Lin, Herndon James E 2nd, Stinchcombe Thomas E, Ready Neal, Crawford Jeffrey, Sonpavde Guru, Balevic Stephen, Nixon Andrew B, Campa Michael, Gottlin Elizabeth B, Li Huihua, Saxena Ruchi, He You Wen, Antonia Scott, Patz Edward F Jr

Development, Review, and Activation of Thoracic Oncology Investigator-Initiated Trials

胸部肿瘤研究者发起试验的开发、审查和启动

Gerber, David E; Wynters, Claire R; Prasad, Tanushree; Schnel, Ronny K; Zhang, Song; Stinchcombe, Thomas E; Villaruz, Liza C; Bauml, Joshua M; Iams, Wade T; Patil, Tejas; Liu, Stephen V; Horn, Leora; Hudak, John M; Camidge, D Ross

Milademetan in Advanced Solid Tumors with MDM2 Amplification and Wild-type TP53: Preclinical and Phase II Clinical Trial Results

米拉德美坦治疗MDM2扩增和TP53野生型晚期实体瘤:临床前和II期临床试验结果

Dumbrava, Ecaterina E; Stinchcombe, Thomas E; Gounder, Mrinal; Cote, Gregory M; Hanna, Glenn J; Sumrall, Bradley; Wise-Draper, Trisha M; Kanaan, Mohammed; Duffy, Steven; Sumey, Christopher; Cobb, Patrick; Forbes, Andre; Beckmann, Aviva G; Schadt, Eric E; Ku, Nora; Tirunagaru, Vijaya G; Singh, Kanchan; Pei, Xinyu; Xu, Feng; Doebele, Robert C; Chen, Christopher T

Multi-Institution Analysis of Tarlatamab for the Treatment of EGFR-Mutant Transformed Small Cell Lung Cancer

Tarlatamab治疗EGFR突变型转化小细胞肺癌的多中心分析

Cooper, Alissa J; Herzberg, Benjamin; Parma, Mitchell; Wang, Kaiwen; Alder, Laura; Weber, Urs M; Patil, Tejas; Joshi, Utsav; Puri, Sonam; Saqi, Anjali; Clark, Phoebe; Gay, Carl M; Cascone, Tina; Singhi, Eric K; Blumenschein, George; Skoulidis, Ferdinandos; Tu, Janet; Stinchcombe, Thomas E; Rudin, Charles M; Shu, Catherine A; Byers, Lauren A; Yu, Helena; Zhang, Bingnan